Zobrazeno 1 - 10
of 890
pro vyhledávání: '"Martin, Schlumberger"'
Autor:
Sophie Leboulleux, Ellen Kapiteijn, Saskia Litière, Patrick Schöffski, Yann Godbert, Patrice Rodien, Barbara Jarzab, Domenico Salvatore, Sylvie Zanetta, Jaume Capdevila, Lars Bastholt, Christelle De La Fouchardiere, Yassine Lalami, Stéphane Bardet, Frank Cornélis, Marek Dedecjus, Thera Links, Ward Sents, Martin Schlumberger, D. Laura Locati, Katie Newbold
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
BackgroundNintedanib is a triple-angiokinase inhibitor with potential activity in patients with advanced thyroid cancers, as radioiodine refractory differentiated thyroid cancer (RAIR DTC) and medullary thyroid cancer (MTC).DesignEORTC-1209 (NCT01788
Externí odkaz:
https://doaj.org/article/6cb94876a3044358996b174c5e0cfcd4
Autor:
Dana Hartl, Yann Godbert, Xavier Carrat, Stéphane Bardet, Audrey Lasne-Cardon, Pierre Vera, Elena Ilies, Slimane Zerdoud, Jérôme Sarini, Mohamad Zalzali, Luigi La Manna, Olivier Schneegans, Antony Kelly, Philppe Kauffmann, Patrice Rodien, Laurent Brunaud, Solange Grunenwald, Elie Housseau, Salim Laghouati, Nathalie Bouvet, Elodie Lecerf, Julien Hadoux, Livia Lamartina, Martin Schlumberger, Isabelle Borget
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-22 (2023)
Abstract Background Prophylactic central neck dissection in clinically low-risk cT1bT2N0 papillary thyroid carcinoma is controversial, due to a large number of conflicting retrospective studies, some showing an advantage in terms of locoregional recu
Externí odkaz:
https://doaj.org/article/bc999fbd4e0b4fbf9b920f11d7dfde0e
Autor:
Furio Pacini, Dagmar Fuhrer, Rossella Elisei, Daria Handkiewicz-Junak, Sophie Leboulleux, Markus Luster, Martin Schlumberger, Johannes W Smit
Publikováno v:
European Thyroid Journal, Vol 11, Iss 1, Pp 1-9 (2023)
Modern use of post-operative radioactive iodine (RAI) treatment for differentiated thyroid cancer (DTC) should be implemented in line with patient s’ risk stratification. Although beneficial effects of radioiodine are undisputed in high -risk patie
Externí odkaz:
https://doaj.org/article/f5bc1da3cd3245e8a6fee2a1cab6f5da
Autor:
Cristina Luongo, Tommaso Porcelli, Francesca Sessa, Maria Angela De Stefano, Francesco Scavuzzo, Vincenzo Damiano, Michele Klain, Claudio Bellevicine, Elide Matano, Giancarlo Troncone, Martin Schlumberger, Domenico Salvatore
Publikováno v:
Current Oncology, Vol 28, Iss 6, Pp 5401-5407 (2021)
Anaplastic thyroid cancer (ATC) is a rare but aggressive thyroid cancer, responsible for about 50% of all thyroid cancer-related deaths. During the last two decades, the development of a multimodal personalized approach resulted in an increased survi
Externí odkaz:
https://doaj.org/article/5ef39cd535e54431bd5163a87cad845a
Autor:
Dana Hartl, Yann Godbert, Xavier Carrat, Stéphane Bardet, Audrey Lasne-Cardon, Pierre Vera, Elena Ilies, Slimane Zerdoud, Jérôme Sarini, Mohamad Zalzali, Luigi La Manna, Olivier Schneegans, Antony Kelly, Philppe Kaufmann, Patrice Rodien, Laurent Brunaud, Solange Grunenwald, Elie Housseau, Salim Laghouati, Nathalie Bouvet, Elodie Lecerf, Julien Hadoux, Livia Lamartina, Martin Schlumberger, Isabelle Borget
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/88b6f8fb78e044519a1c3f2d576029f0
Autor:
Michele Klain, Valeria Gaudieri, Mario Petretta, Emilia Zampella, Giovanni Storto, Carmela Nappi, Carlo Buonerba, Felice Crocetto, Rosj Gallicchio, Fabio Volpe, Leonardo Pace, Martin Schlumberger, Alberto Cuocolo
Publikováno v:
Future Science OA, Vol 7, Iss 8 (2021)
Aim: To assess the value of bone scintigraphy and 18F-fluorocholine PET/computed tomography (CT) in predicting outcome in patients with prostate cancer and bone metastases treated with 223radium. Materials & methods: Retrospective analysis of 48 pati
Externí odkaz:
https://doaj.org/article/71253ca774274a6e91d4829a72c01dc9
Autor:
Joachim Grevel, Garrit Jentsch, Rupert Austin, Nicolaas H. Prins, John Lettieri, David Mitchell, Funan Huang, Marcia S. Brose, Martin Schlumberger, Gerold Meinhardt, Carol E. A. Peña, Bart A. Ploeger
Publikováno v:
Clinical and Translational Science, Vol 12, Iss 5, Pp 459-469 (2019)
Sorafenib is an oral multikinase inhibitor approved for the treatment of differentiated thyroid carcinoma (DTC), renal cell carcinoma, and hepatocellular carcinoma. In the phase III DECISION trial in patients with DTC, sorafenib exposure and the inci
Externí odkaz:
https://doaj.org/article/f459c9a764c849519f2e779c790d916b
Autor:
Denis Horgan, Dagmar Führer-Sakel, Paula Soares, Clara V. Alvarez, Laura Fugazzola, Romana T. Netea-Maier, Barbara Jarzab, Marta Kozaric, Beate Bartes, James Schuster-Bruce, Luigino Dal Maso, Martin Schlumberger, Furio Pacini
Publikováno v:
Healthcare, Vol 10, Iss 9, p 1621 (2022)
Thyroid cancer (TC) is the most common malignancy of the endocrine system that affects the thyroid gland. It is usually treatable and, in most cases, curable. The central issues are how to improve knowledge on TC, to accurately identify cases at an e
Externí odkaz:
https://doaj.org/article/47bcda19d0bf4390aeba6cf75f92e559
Autor:
Sophie Leboulleux, Christine Do Cao, Slimane Zerdoud, Marie Attard, Claire Bournaud, Ludovic Lacroix, Danielle Benisvy, David Taïeb, Stéphane Bardet, Marie Terroir-Cassou-Mounat, Nadège Anizan, Emilie Bouvier-Morel, Livia Lamartina, Georges Lion, Sarah Betrian, Christophe Sajous, Aurélie Schiazza, Marie-Eve Garcia, Renaud Ciappuccini, Martin Schlumberger, Abir Al Ghuzlan, Yann Godbert, Isabelle Borget
Publikováno v:
Clinical Cancer Research. :OF1-OF9
Purpose: To evaluate the efficacy and safety of dabrafenib-trametinib-131I for the treatment of radioactive iodine refractory metastatic differentiated thyroid cancer (DTC) with a BRAF p.V600E mutation. Patients and Methods: A prospective phase II tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90b1a9690ff12239a90cfbd03e7079a7
https://doi.org/10.1158/1078-0432.ccr-23-0046
https://doi.org/10.1158/1078-0432.ccr-23-0046
Autor:
Julien Hadoux, Christophe Desterke, Olivier Féraud, Mathieu Guibert, Roberta Francesca De Rose, Paule Opolon, Dominique Divers, Emilie Gobbo, Frank Griscelli, Martin Schlumberger, Annelise Bennaceur-Griscelli, Ali G. Turhan
Publikováno v:
Stem Cell Research, Vol 26, Iss , Pp 8-16 (2018)
Summary: MEN2A is a hereditary cancer-predisposing syndrome that affects patients with germline RET mutations. The effects of this oncogenic tyrosine kinase in the context of primitive stem cells are not known. In order to study these events, we gene
Externí odkaz:
https://doaj.org/article/6b8edb93b8224b969313efc275e52ecf